StockerBroker

Maybe a runner

看多
NASDAQ:ENTX   Entera Bio Ltd.
This has news AH that clinical trials have good results. 70% success rate. Went above its previous support of $3.80 from March of 2019 and stayed above that all day. If it bounces of that support in the morning dip, would be an excellent point to buy.

Second resistance level is around $5. If it breaks that before open then that's a clear breakout.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。